NCT06236802View on ClinicalTrials.gov

ProVIDE II Bridging Study

NAActive, not recruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

March 6, 2024

Primary Completion Date

September 6, 2024

Study Completion Date

June 1, 2029

Conditions
BPH With Symptomatic Lower Urinary Tract Symptoms
Interventions
DEVICE

ProVee device

ProVee Expander is placed in prostatic urethra to relieve obstruction due to BPH.

Trial Locations (8)

33606

Florida Urology Partners, LLP, Tampa

34787

Avant Concierge Urology, Winter Garden

60010

Comprehensive Urologic Care, Lake Barrington

78705

Midtown Urology Assoc. PA, Austin

78745

Urology Austin, Austin

89144

Sheldon Freeman MD LTD, Las Vegas

770030

Houston Methodist Research Institute, Houston

Unknown

St James Hospital, Dublin

Sponsors

Lead Sponsor

ProVerum Medical
All Listed Sponsors
lead

ProVerum Medical

INDUSTRY